Pool Corp (POOL) Shares Surge 3.7% -- What GF Score of 76 Tells Investors
Pool Corp (POOL) shares surged 3.7% on June 16, 2026, closing at $198.08. The company's GF Score of 76/100 indicates above-average quality and potential for long-term returns, with strong profitability. Despite this, the stock is considered significantly undervalued by GuruFocus's GF Value, suggesting a potential upside. Insider buying worth $4.0 million in the last three months also signals strong confidence in the company's future.
Align Technology Shifts Focus From Individual Products to a Connected Platform
Align Technology is shifting its strategy from individual product announcements to a unified, connected platform aimed at reducing clinical friction and enhancing digital capabilities for orthodontists. This new approach, highlighted at the 2026 AAO Annual Session, focuses on streamlining digital workflows, automating chairside processes像attachment placement and button delivery, and expanding clinical flexibility to simplify complex and advanced cases while supporting doctor-driven treatment decisions. The goal is to improve predictability, enhance the patient experience, and support practice growth by integrating all aspects into a seamless digital system.
Personalis (PSNL) Stock Could Be 10% Undervalued After ASCO Cancer Data
Personalis (PSNL) stock is under scrutiny after new clinical data presented at the 2026 ASCO meeting showed its NeXT Personal test's effectiveness in detecting minimal residual disease across six solid tumor types. Despite a significant recent stock rally, the company might still be 10% undervalued, with potential for increased profitability driven by upcoming Medicare coverage decisions. However, a high price-to-sales ratio and potential delays in reimbursement or intensified competition pose risks to its future performance.
Is Paycom Software Inc (PAYC) a Bargain After 4.1% Drop? GF Value Says Undervalued
Paycom Software Inc (PAYC) shares recently dropped by 4.1%, but GuruFocus's GF Value suggests the stock is significantly undervalued, currently trading at $129.13 against a GF Value of $252.65. The company boasts a strong GF Score of 82/100 due to high profitability and growth, though its valuation and momentum ranks are lower. Despite no recent insider transactions, the analysis indicates a potential buying opportunity for long-term investors.
Teradyne director Marilyn Matz sells $507,635 in company stock
Marilyn Matz, a director at Teradyne Inc., sold 1,200 shares of the company's common stock for $507,635 on June 15, 2026. This transaction was conducted under a Rule 10b5-1 trading plan adopted in February 2026. The sale occurred after a significant 368% return for Teradyne over the past year, though the stock is currently considered overvalued relative to its Fair Value by InvestingPro analysis.
Pfizer trades up with Rigel’s Veppanu deal done
Pfizer's stock edged up 0.15% after Rigel Pharmaceuticals finalized a licensing agreement for Veppanu, a breast cancer treatment developed by Arvinas and Pfizer. The deal includes a $70 million upfront payment, split between Arvinas and Pfizer, and aims to boost Pfizer's oncology pipeline amid concerns about falling COVID sales and upcoming patent expirations. Investors are looking for clearer signs that new drugs and acquisitions can drive future growth for the company.
EA (EA) CFO Stuart Canfield receives 60,309 restricted stock units in equity grant
Electronic Arts Inc.'s CFO Stuart Canfield was granted 60,309 Restricted Stock Units (RSUs) as part of his compensation. These RSUs will vest in increments starting May 15, 2027, and fully by May 15, 2029, with each RSU representing one share of EA common stock upon settlement. The grant aligns the executive's interests with shareholder value and follows standard equity compensation practices.
Why Albemarle (ALB) Dipped More Than Broader Market Today
Albemarle (ALB) shares dipped by 1.65%, underperforming the S&P 500, but the company shows strong growth potential. Its EPS is projected to increase by 2700% from last year, and revenue is expected to grow by 11.36%, leading to a Zacks Rank of #1 (Strong Buy). Despite the recent dip, its valuation metrics like Forward P/E and PEG ratio suggest it is currently undervalued compared to its industry.
Is It Too Late to Buy MarketAxess Holdings Inc (MKTX) After 3.1% Rally? GF Value Says Undervalued
MarketAxess Holdings Inc (MKTX) shares rallied 3.1% recently, yet GuruFocus's GF Value indicates the stock is significantly undervalued at $124.81 compared to its GF Value of $252.72. The stock's P/E ratio is also substantially lower than its historical median, reinforcing the undervaluation despite recent price declines and a lack of insider trading activity. MKTX has strong financial health, profitability, and growth ratings, but weak momentum and valuation scores.
eBay layoffs coincide with new H-1B hiring
E-commerce giant eBay plans to lay off 639 U.S. employees while simultaneously filing applications for 429 H-1B visa hires in 2026. This practice has reignited debates about the H-1B program, with critics arguing against visa-sponsored recruitment during workforce reductions, while supporters claim it addresses specialized talent shortages. Despite strong business performance and previous job cuts in 2024, the simultaneous layoffs and H-1B hiring are drawing scrutiny in the tech sector.


